Arbutus Biopharma Corp (NASDAQ:ABUS)
| 2.88 Delayed Data As of Jul 05 |  +0.08 / +2.86%Today’s Change | 1.93 Today|||52-Week Range 6.50 | -25.96% Year-to-Date |
Latest ABUS News | Press Releases
No recent news for Arbutus Biopharma Corp.
Today’s Trading
| Previous close | 2.80 |
| Today’s open | 2.79 |
| Day’s range | 2.77 - 2.99 |
| Volume | 1,571,864 |
| Average volume (3 months) | 1,508,518 |
| Market cap | $419.4M |
Data as of 3:59pm ET, 07/05/2022
Growth & Valuation
| Earnings growth (last year) | +16.84% |
| Earnings growth (this year) | +37.83% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +58.92% |
| P/E ratio | NM |
| Price/Sales | 37.61 |
| Price/Book | 2.41 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KPTIKaryopharm Therapeut... | +0.58 | +12.26% |
| ALBOAlbireo Pharma Inc | +1.16 | +5.49% |
| ---- | ||
| AFMDAffimed NV | +0.19 | +6.76% |
Data as of 4:00pm ET, 07/05/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $11.0M |
| Annual profit (last year) | -$76.2M |
| Net profit margin | -693.91% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Warminster, Pennsylvania |
Forecasts
